Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $3.94 million. The enterprise value is $104,110.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 2.94 million shares outstanding.
| Current Share Class | 2.94M |
| Shares Outstanding | 2.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +118.34% |
| Owned by Insiders (%) | 99.82% |
| Owned by Institutions (%) | 0.05% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.57 |
| Forward PS | 77.20 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.43 |
| Quick Ratio | 4.55 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -177.57% and return on invested capital (ROIC) is -187.02%.
| Return on Equity (ROE) | -177.57% |
| Return on Assets (ROA) | -84.69% |
| Return on Invested Capital (ROIC) | -187.02% |
| Return on Capital Employed (ROCE) | -128.19% |
| Revenue Per Employee | $6,750 |
| Profits Per Employee | -$581,167 |
| Employee Count | 12 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $1.20 million in taxes.
| Income Tax | 1.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.52% in the last 52 weeks. The beta is -0.19, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -98.52% |
| 50-Day Moving Average | 3.60 |
| 200-Day Moving Average | 29.31 |
| Relative Strength Index (RSI) | 27.77 |
| Average Volume (20 Days) | 823,613 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BGMS had revenue of $81,000 and -$6.97 million in losses. Loss per share was -$3.65.
| Revenue | 81,000 |
| Gross Profit | 17,000 |
| Operating Income | -9.17M |
| Pretax Income | -4.24M |
| Net Income | -6.97M |
| EBITDA | -9.17M |
| EBIT | -9.17M |
| Loss Per Share | -$3.65 |
Full Income Statement Balance Sheet
The company has $3.84 million in cash and $5,000 in debt, giving a net cash position of $3.83 million or $1.30 per share.
| Cash & Cash Equivalents | 3.84M |
| Total Debt | 5,000 |
| Net Cash | 3.83M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 7.10M |
| Book Value Per Share | 3.71 |
| Working Capital | 5.44M |
Full Balance Sheet Margins
| Gross Margin | 20.99% |
| Operating Margin | -11,324.69% |
| Pretax Margin | -5,238.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |